Mediastinal lymph node CD8α- DC initiate antigen presentation following intranasal coadministration of α-GalCer

European Journal of Immunology

Volumn 37, Issue 8, 2007, Pages 2127-2137

  Ko, Sung Youl ^a   Lee, Kyoo A ^a   Youn, Hyun Jun ^a   Kim, Yeon Jeong ^a   Ko, Hyun Jeong ^a   Heo, Tae Hwe ^b   Kweon, Mi Na ^c   Kang, Chang Yuil ^a  

^a Seoul National University   (South Korea)

^b Konyang University   (South Korea)

^c International Vaccine Institute   (South Korea)

Author keywords

DC subset; Mucosa; Nasal vaccination; Natural killer T cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD45 ANTIGEN; CD8ALPHA ANTIGEN; GLYCOPROTEIN P 15095;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; EFFECTOR CELL; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; INOCULATION; LYMPHOCYTE DIFFERENTIATION; MEDIASTINUM LYMPH NODE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; IMMUNITY, MUCOSAL; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOCYTE ACTIVATION; MEDIASTINUM; MICE; OVALBUMIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 34547907071     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636909     Document Type: Article

References (39)

1. Kawano, T., Cui J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H. et al., CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
2. Van Kaer, L., Alpha-galactosylceramide therapy for autoimmune diseases: Prospects and obstacles. Nat. Rev. Immunol. 2005. 5: 31-42.
3. Gonzalez-Aseguinolaza, G., Van Kaer, L., Bergmann, C. C., Wilson, J. M., Schmieg, J., Kronenberg, M., Nakayama, T. et al., Natural killer T cell tigand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 2002. 195: 617-624.
4. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T. et al., The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 1052-1056.
5. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M. et al., Activation of natural killer T cells by alpha-gatactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
6. Yuki, Y. and Kiyono, H., New generation of mucosal adjuvants for the induction of protective immunity. Rev. Med. Virol. 2003. 13: 293-310.
7. Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. and Steinman, R. M., Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 2003. 198: 267-279.
8. Silk, J. D., Hermans, I. F., Gileadi, U., Chong, T. W., Shepherd, D., Salio, M., Mathew, B. et al., Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J. Clin. Invest. 2004. 114: 1800-1811.
9. Ko, S. Y., Ko, H. J., Chang, W. S., Park, S. H., Kweon, M. N. and Kang, C. Y., Alpha-galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J. Immunol. 2005. 175: 3309-3317.
10. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003. 21: 685-711.
11. Moser, M., Dendritic cells in immunity and tolerance-do they display opposite functions? Immunity 2003. 19: 5-8.
12. Gad, M., Claesson, M. H. and Pedersen, A. E., Dendritic cells in peripheral tolerance and immunity. Apmis 2003. 111: 766-775.
13. Chung, Y., Chang, W. S., Kim, S. and Kang, C. Y., NKT cell ligand alpha-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation. Eur. J. Immunol. 2004. 34: 2471-2479.
14. Shortman, K. and Liu, Y. J., Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002. 2: 151-161.
15. + dendritic cells. J. Immunol. 2001. 166: 5327-5330.
16. Beiz, G. T., Behrens, G. M., Smith, C. M., Miller, J. F., Jones, C., Lejon, K., Fathman, C. G. et al., The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to time-associated antigens. J. Exp. Med. 2002. 196: 1099-1104.
17. Smith, C. M., Belz, G. T., Wilson, N. S., Villadangos, J. A., Shortman, K., Carbone, F. R. and Heath, W. R., Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 2003. 170: 4437-4440.
18. + dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 2004. 172: 1996-2000.
19. + dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 2005. 175: 196-200.
20. + dendritic cells mediate cross-tolerance toward intestinal antigens. Blood 2005. 106: 201-206.
21. - APC in mouse spleen. J. Immunol. 2004. 173: 2362-2372.
22. Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman D. R., Cumano, A. and Geissmann, F., A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006. 311: 83-87.
23. + T cells. J. Immunol. 1999. 163: 2592-2600.
24. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. and Wakao, H., The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 2003. 21: 483-513.
25. Fujii, S., Shimizu K., Kronenberg, M. and Steinman, R. M., Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat. Immunol. 2002. 3: 867-874.
26. Duverger, A., Jackson, R. J., van Ginkel, F. W., Fischer, R., Tafaro, A., Leppla, S. H., Fujihashi, K. N. et al., Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens. J. Immunol. 2006. 176: 1776-1783.
27. Kweon, M. N., Yamamoto, M., Watanabe, F., Tamura, S., Van Ginkel, F. W., Miyauchi A., Takagi, H. et al., A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies. J. Infect. Dis. 2002. 186: 1261-1269.
28. Wolvers, D. A., Coenen-de Roo, C. J., Mebius, R. E., van der Cammen, M. J., Thion, F., Miltenburg, A. M. and Kraal, G., Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: Studies with OVA and human cartilage gp-39. J. Immunol. 1999. 162: 1994-1998.
29. + T cells in airway inflammation and tolerance. J. Immunol. 2005. 174: 854-863.
30. Brimnes, M. K., Bonifaz, L., Steinman, R. M. and Moran, T. M., Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein. J. Exp. Med. 2003. 198: 133-144.
31. Wiley, J. A., Tighe, M. P. and Harmsen, A. G., Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes. J. Immunol. 2005. 175: 3186-3196.
32. Chung, Y., Kim, B. S., Kim, Y. J., Ko, H. J., Ko, S. Y., Kim, D. H. and Kang, C. Y., CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo. Cancer Res. 2006. 66: 6843-6850.
33. Lutz, M. B. and Schuler, G., Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends Immunol. 2002. 23: 445-449.
34. Morelli, A. E. and Thomson, A. W., Dendritic cells: Regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 2003. 196: 125-446.
35. Chung, Y., Chang, J. H., Kim, B. S., Lee, J. M., Kim, H. Y. and Kang, C. Y., Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens. Eur. J. Immunol. 2007. DOI 10.1002/eji.200636544
36. Skold, M., Xiong, X., Illarionov, P. A., Besra, G. S. and Behar, S. M., Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation. J. Immunol. 2005. 175: 3584-3593.
37. Szatmari, I., Pap, A., Ruhl, R., Ma, J. X., Illarionov, P. A., Besra, G. S., Rajnavolgyi, E. et al., PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 2006. 203: 2351-2362.
38. Kim H. J., Kim H. Y., Kim B. K., Kim, S. and Chung, D. H., Engagement of glucocorticoid-induced TNF receptor costimulates NKT cell activation in vitro and in vivo. J. Immunol. 2006. 176: 3507-3515.
39. Takikawa, H., Muto, S.-F. and Mori, K., Diastereoselective epoxidation of the double bond at C-4 of sphingosines to provide phytosphingosine relatives such as alpha-galactosylceramide KRN7000. Tetrahedron 1998. 54: 3141-3150.